What Does Nimble Therapeutics Do?

Total employees36
HeadquartersMadison
Founded2019

Nimble Therapeutics is a biotechnology company dedicated to transforming drug discovery through its proprietary platform for peptide synthesis, screening, and optimization. They focus on rapidly identifying and advancing novel peptide-based therapeutics against challenging disease targets that have been difficult to address with traditional drug modalities. Their approach combines massively parallel chemical synthesis with advanced screening and machine learning to accelerate the development of new medicines.

Where Is Nimble Therapeutics's Headquarters?

HQ Function

Primary center for research and development, high-throughput peptide synthesis and screening, computational biology, and corporate operations.

Notable Features:

State-of-the-art laboratory facilities designed for advanced peptide chemistry, biological screening, and data analysis. Likely incorporates collaborative workspaces to foster innovation.

Work Culture:

Nimble Therapeutics likely fosters a highly innovative, science-driven, and collaborative work environment. Employees are expected to be agile and contribute to a fast-paced drug discovery process, with a strong emphasis on teamwork and problem-solving.

HQ Significance:

The Madison headquarters is central to Nimble's operations, housing its core technology platform and the scientific expertise driving its drug discovery pipeline. Its location in a recognized biotech hub provides access to talent and research collaborations.

Values Reflected in HQ: The headquarters likely reflects values of innovation, precision, collaboration, and a commitment to scientific excellence in tackling challenging diseases.

Location:

While Nimble Therapeutics's primary physical operations are centered in Madison, Wisconsin, its impact and collaborations are global. The company engages with international pharmaceutical partners, research institutions, and contract research organizations to advance its pipeline and leverage its platform technology worldwide. Their drug candidates are being developed for potential global markets.

Street Address:

630 W Washington Ave, Suite 300

City:

Madison

State/Province:

Wisconsin

Country:

USA

Where Else Does Nimble Therapeutics Operate Around the World?

No additional office locations available.

Buying Intent Signals for Nimble Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading Nimble Therapeutics? Meet the Executive Team

As of April 2025, Nimble Therapeutics' leadership includes:

Jigar Patel, PhD - Chief Executive Officer
Pete Gough, PhD - Chief Scientific Officer
Rafael Q. Diaz, PhD - Vice President, Head of Discovery
Brad Garcia, PhD - Vice President, Corporate Development
Jessica Chery - Vice President, Finance & Operations

Who's Investing in Nimble Therapeutics?

Nimble Therapeutics has been backed by several prominent investors over the years, including:

Deerfield Management
Longitude Capital
GV (Google Ventures)
Catalio Capital Management
Agent Capital
Incyte Corporation (strategic collaboration)

What Leadership Changes Has Nimble Therapeutics Seen Recently?

Hire0
Exits0

Based on publicly available information, Nimble Therapeutics has maintained a relatively stable core executive team. No major high-profile executive hires or departures have been widely announced in the last 12-18 months, suggesting continuity in leadership.

What Technology (Tech Stack) Is Used byNimble Therapeutics?

Discover the tools Nimble Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Nimble Therapeutics Email Formats and Examples

Nimble Therapeutics likely utilizes a common corporate email format. The most probable pattern is the first initial followed by the last name.

[first_initial][last]@nimbletherapeutics.com

Format

jpatel@nimbletherapeutics.com

Example

80%

Success rate

What's the Latest News About Nimble Therapeutics?

Business WireOctober 19, 2023

Nimble Therapeutics and Incyte Announce Exclusive Worldwide License and Collaboration Agreement for Novel Oral Peptide Antagonist Program

Nimble Therapeutics and Incyte entered into an exclusive worldwide license and collaboration agreement for Nimble’s oral 3CL protease (Mpro) antagonist program, NHL-338, for SARS-CoV-2 and other coronaviruses. Nimble will receive an upfront payment and is eligible for development, regulatory, and commercial milestones, plus royalties....more

Nimble Therapeutics Press Release / Business WireOctober 16, 2023

Nimble Therapeutics Presents Preclinical Data on Oral GLP-1/GIP/Glucagon Tri-Agonist Program at ObesityWeek® 2023

Nimble Therapeutics presented preclinical data for its lead oral GLP-1/GIP/Glucagon tri-agonist candidate, NBL-015, at ObesityWeek® 2023. The data demonstrated significant weight loss, improved glycemic control, and favorable tolerability in preclinical models, supporting its potential as a best-in-class oral treatment for obesity and related metabolic diseases....more

Business WireFebruary 7, 2023

Nimble Therapeutics Announces Closing of $50 Million Series C Financing

Nimble Therapeutics announced the closing of a $50 million Series C financing round co-led by new investors Deerfield Management and Longitude Capital, with participation from existing investors GV, Catalio Capital Management, and Agent Capital. The funds will be used to advance its pipeline of novel peptide therapeutics and further develop its proprietary drug discovery platform....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Nimble Therapeutics, are just a search away.